EQUILLIUM, INC. (EQ) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $850.00K; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $850.00K | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $850.00K |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 2.65M USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 850.00K USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Deferred Revenue, Current · Deferred Revenue, Noncurrent |
| Deferred revenue due within one year | (m) | Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Deferred Revenue, Noncurrent · Deferred Revenue, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | (m) | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $584.00K |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $850.00K | (m) | (m) | (m) | $2.65M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $1.29M | (m) | (m) | (m) | $3.60M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $755.00K | (m) | (m) | (m) | $3.29M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $1.08M | (m) | (m) | (m) | $3.57M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $4.81M | (m) | (m) | (m) | $7.34M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $3.06M | (m) | (m) | (m) | $6.15M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $2.68M | (m) | (m) | (m) | $6.54M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $3.67M | (m) | (m) | (m) | $11.28M | (m) | $2.07M | (m) | (m) | (m) |
| 2024-06-30 | (m) | $4.49M | (m) | (m) | (m) | $20.43M | (m) | $8.43M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $2.78M | (m) | (m) | (m) | $22.50M | (m) | $13.36M | (m) | (m) | (m) |
| 2023-12-31 | (m) | $4.71M | (m) | (m) | (m) | $27.96M | (m) | $15.73M | (m) | (m) | (m) |
| 2023-09-30 | (m) | $3.63M | $18.25M | (m) | (m) | $31.12M | (m) | $15.83M | $2.42M | (m) | $0.00 |
| 2023-06-30 | (m) | $3.03M | $20.20M | (m) | (m) | $31.78M | (m) | $14.24M | $5.96M | (m) | $0.00 |
| 2023-03-31 | (m) | $5.69M | $22.71M | (m) | (m) | $42.52M | (m) | $14.77M | $7.94M | (m) | $0.00 |
| 2022-12-31 | (m) | $3.98M | $25.08M | (m) | (m) | $46.48M | (m) | $14.70M | $10.38M | (m) | $0.00 |
| 2022-09-30 | (m) | $2.47M | (m) | (m) | (m) | $20.47M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $5.09M | (m) | (m) | (m) | $22.20M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $4.21M | (m) | (m) | (m) | $21.61M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.23M | (m) | (m) | (m) | $18.90M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $2.67M | (m) | (m) | (m) | $16.67M | (m) | (m) | (m) | $17.00K | (m) |
| 2021-06-30 | (m) | $1.82M | (m) | (m) | (m) | $15.06M | (m) | (m) | (m) | $17.00K | (m) |
| 2021-03-31 | (m) | $2.32M | (m) | (m) | (m) | $14.96M | (m) | (m) | (m) | $35.00K | (m) |
| 2020-12-31 | (m) | $2.77M | (m) | (m) | (m) | $15.57M | (m) | (m) | (m) | $54.00K | (m) |
| 2020-09-30 | (m) | $1.68M | (m) | (m) | (m) | $14.26M | (m) | (m) | (m) | $71.00K | (m) |
| 2020-06-30 | (m) | $1.76M | (m) | (m) | (m) | $13.29M | (m) | (m) | (m) | $90.00K | (m) |
| 2020-03-31 | (m) | $1.80M | (m) | (m) | (m) | $13.56M | (m) | (m) | (m) | $108.00K | (m) |
| 2019-12-31 | (m) | $1.87M | (m) | (m) | (m) | $13.69M | (m) | (m) | (m) | $127.00K | (m) |
| 2019-09-30 | (m) | $2.67M | (m) | (m) | (m) | $14.04M | (m) | (m) | (m) | $146.00K | (m) |
| 2019-06-30 | (m) | $1.97M | (m) | (m) | (m) | $3.83M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $1.59M | (m) | (m) | (m) | $3.23M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.12M | (m) | (m) | (m) | $2.23M | (m) | (m) | (m) | $199.53K | (m) |
| 2018-09-30 | (m) | $1.23M | (m) | (m) | (m) | $16.80M | (m) | (m) | (m) | $148.72K | (m) |
| 2017-12-31 | (m) | $243.74K | (m) | (m) | (m) | $9.40M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |